Sanofi-Aventis: WhyInsulin.com

Choosing to begin insulin therapy can be a frightening choice for patients. Euro RSCG Life was brought on board to reach diabetes patients and help them make informed decisions. A lightly-branded consumer microsite was developed to provide educational information and to let patients see that insulin use can be an acceptable form of treatment. In addition, the site guided users toward the LANTUS SoloSTAR pen and offered a free meal planning guide for users who registered. Since launch, more than 1,300 people have registered on the site.